d-Psicose Inhibits Intestinal alpha-Glucosidase and Suppresses the Glycemic Response after Ingestion of Carbohydrates in Rats

Tatsuhiro Matsuo, Ken Izumori, Tatsuhiro Matsuo, Ken Izumori

Abstract

d-psicose is one of the rare sugars present in small quantities in commercial carbohydrates and agricultural products. In this study, we investigated the effects of d-psicose on the activities of alpha-amylases and alpha-glucosidases in vitro, and evaluated the effects of d-psicose on the in vivo postprandial glycemic response using rats. In the in vitro study, d-psicose potently inhibited the intestinal sucrase and maltase, however, slightly inhibited the intestinal and salivary alpha-amylase activities. Male Wistar rats (6 months old) were administrated 2 g/kg of sucrose, maltose or soluble starch together with 0.2 g/kg of d-psicose or d-fructose. The d-psicose significantly inhibited the increment of plasma glucose concentration induced by sucrose or maltose. The starch-induced glycemic response tended to be suppressed by d-psicose, however the suppression was not significant. These results suggest that d-psicose inhibits intestinal sucrase and maltase activities and suppresses the plasma glucose increase the normally occurs after sucrose and maltose ingestion. Thus, d-psicose may be useful in preventing postprandial hyperglycemia in diabetic patients when foods containing sucrose and maltose are ingested.

Keywords: d-psicose; maltase; plasma glucose; rat; sucrase.

References

    1. Green G.M., Perlin A.S. O-Isopropylidene derivatives of d-allulose (d-psicose) and d-erythro-hexopyranose-2,3-diulose. Can. J. Biochem. 1968;46:765–770.
    1. Granstrom T.B., Takata G., Tokuda M., Izumori K. Izumoring: a novel and complete strategy for bioproduction of rare sugars. J. Biosci. Bioeng. 2004;97:89–94.
    1. Matsuo T., Suzuki H., Hashiguchi M., Izumori K. d-Psicose is a rare sugar that provides no energy to growing rats. J. Nutr. Sci. Vitaminol. 2002;48:77–80.
    1. Matsuo T., Baba Y., Hashiguchi M., Takeshita K., Izumori K., Suzuki H. Dietary d-psicose, a C-3 epimer of d-fructose, suppresses the activity of hepatic lipogenic enzymes in rats. Asia Pacific J. Clin. Nutr. 2001;10:233–237.
    1. Matsuo T., Baba Y., Hashiguchi M., Takeshita K., Izumori K., Suzuki H. Less body fat accumulation with d-psicose diet versus d-fructose diet. J. Clin. Biochem. Nutr. 2001;30:55–65.
    1. Matsuo T., Tanaka T., Hashiguchi M., Izumori K., Suzuki H. Effects of oral acute administration and subchronic feeding of several levels of d-psicose in rats. J. Nutr. Sci. Vitaminol. 2002;48:512–516.
    1. Matsuo T., Tanaka T., Hashiguchi M., Izumori K., Suzuki H. Metabolic effects of d-psicose in rats: studies on faecal and urinary excretion and caecal fermentation. Asia Pacific J. Clin. Nutr. 2003;12:225–231.
    1. The Diabetes Control and Complications Trial Research Group, author. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent-diabetes mellitus. N. Engl. J. Med. 1993;329:977–986.
    1. Toeller M. Nutritional recommendations for diabetic patients and treatment with α-glucosidase inhibitors. Drugs. 1992;44 Suppl. 3:13–20.
    1. Lebovitz H.E. Oral antidiabetic agents: The emergence of α-glucosidase inhibitors. Drugs. 1992;44 Suppl. 3:21–28.
    1. Puls W., Keup U., Krause H.P. Glucosidase inhibition: A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia. Naturwissenschaften. 1977;64:536–537.
    1. Caspary W.F., Graf S. Inhibition of human intestinal α-glucosidase hydrolases by a new complex oligosaccharide. Res. Exp. Med. 1979;175:1–6.
    1. Puls W., Keup U., Krause H.P. Pharmacology of α-glucosidase inhibitor. Front Horm. Res. 1980;7:235–247.
    1. Seri K., Sanai K., Matsuo N., Kawakubo K., Xue C., Inoue S. l-Arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic response after sucrose ingestion in animals. Metabolism. 1996;45:1368–1374.
    1. Sanai K., Seri K., Inoue S. Inhibition of sucrose digestion and absorption by l-arabinose in rats. J. Jpn. Soc. Nutr. Food Sci. 1997;50:133–137.
    1. Hizukuri S. Nutritional and physiological functions and uses of l-arabinose. J. Appl. Glycosci. 1999;45:159–165.
    1. Inoue S., Sanai K., Seri K. Effect of l-arabinose on blood glucose level after ingestion of sucrose-containing food in human. J. Jpn. Soc. Nutr. Food Sci. 2000;53:243–247.
    1. Matsuo T., Izumori K. Effects of supplemental d-psicose on glucose tolerance and serum adipocytokine levels in rats fed a high-fat diet or a low-fat diet. J. Oleo. Sci. 2004;53:453–460.
    1. Matsuo T. Inhibitory effects of d-psicose on glycemic responses after oral carbohydrate tolerance test in rats. J. Jpn. Soc. Nutr. Food Sci. 2006;59:119–121.
    1. Matsuo T., Izumori K. Effects of dietary d-psicose on diurnal variation in plasma glucose and insulin concentrations of rats. Biosci. Biotechnol. Biochem. 2006;70:2081–2085.
    1. Dahlqvist A. In: Intestinal disaccharidases. in Methods in Enzymology, vol. 8, Complex Carbohydrates. Neufeld E.F., Ginsburg V., editors. Academic Press; New York: 1966. pp. 584–951.
    1. Whelan W.J. In: Hydrolysis with α-amylase. in Carbohydrate Chemistry, vol. 4, Starch. Whistler R.L., editor. Academic Press; New York: 1964. pp. 252–260.
    1. Semenza G., Balthazar A.K. Steady-state kinetics of rabbit intestinal sucrase: Kinetic mechanism, Na+ activation, inhibition by Tris (hydroxymethyl) aminomethane at the glucose subsite. Eur. J. Biocem. 1974;41:149–162.
    1. Miura T., Koide T., Ohichi R., Kako M., Usami M., Ishihara E., Yasuda N., Ishida H., Seino Y., Tanigawa K. Effect of acarbose (α-glucosidase inhibitor) on disaccharase activity in small intestine in KK-Ay and ddY Mice. J. Nutr. Sci. Vitaminol. 1988;44:371–379.
    1. Puls W., Keup U. Inhibition of sucrase by Tris in rats and man, demonstrated by oral loading tests with sucrose. Metabolism. 1975;24:93–98.
    1. Cree G.M., Perlin A.S. O-Isopropylidene derivatives of d-allulose (d-psicose) and d-erythro-hexopyranose-2,3-diulose. Can. J. of Biochem. 1968;46:765–770.
    1. Binkley W.W. The fate of cane juice simple sugars during molasses formation IV. Probable conversion of d-fructose to d-psicose. Int. Sugar J. 1963;65:105–106.
    1. Miller B.S., Swain T. Chromatographic analyses of the free amino acids, organic acids and sugars in wheat plant extracts. J. Sci. Food Agric. 1960;11:344–348.
    1. Hough L., Stacey B.E. Variation in the allitol content of Itea plants during photosynthesis. Phytochemistry. 1966;5:171–175.
    1. Eble T.E., Hoeksema H., Boyack G.A., Savage G.M. Psicofuranine. I. Discovery, isolation, and properties. Antibiot. Chemother. 1959;9:419–420.
    1. The Ministry of Health and Welfare, Japan, author. Information on Adverse Reactions to Drugs. no. 129, Tokyo, Japan. 1994. pp. 2–3.
    1. Kaiser T., Sawicki P.T. Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data. Diabetologia. 2004;47:575–580.
    1. Van De Laar F.A., Lucassen P.L.B.J. No evidence for a reduction of myocardial infarctions by acarbose. Eur. Heart J. 2004;25:1179.
    1. Van De Laar F.A., Lucassen P.L.B.J., Akkermans R.P., Van De Lisdonk E.H., Rutten G.E., Van Weel C. α-Glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care. 2005;28:154–163.
    1. Yagi K., Matsuo T. The study on long-term toxicity of d-psicose in rats. J. Clin. Biochem. Nutr. in press.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel